Israel -
hebraisk -
Ministry of Health
פירזיר 30 מג
takeda israel ltd - icatibant as acetate - תמיסה להזרקה - icatibant as acetate 30 mg / 3 ml - icatibant
Israel -
hebraisk -
Ministry of Health
אלבומין הומני טקדה 200מגמל תמיסה לעירוי
takeda israel ltd - albumin human - תמיסה לאינפוזיה - albumin human 200 mg / 1 ml - albumin
Israel -
hebraisk -
Ministry of Health
אלבומין הומני טקדה 50 מגמל תמיסה לעירוי
takeda israel ltd - albumin human - תמיסה לאינפוזיה - albumin human 50 mg / 1 ml - albumin
Israel -
hebraisk -
Ministry of Health
היקיוביה
takeda israel ltd - human normal immunoglobulin - תמיסה לאינפוזיה - human normal immunoglobulin 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm.
Israel -
hebraisk -
Ministry of Health
אלופיסל
takeda israel ltd - darvadstrocel - תרחיף להזרקה - darvadstrocel 5000000 cells/ml - darvadstrocel
Israel -
hebraisk -
Ministry of Health
סינקטן דפו 1 מ"ג/1 מ"ל
novartis pharma services ag - tetracosactide hexaacetate 1 mg/ml - suspension for injection - tetracosactide - collagen diseases, neurological diseases, chronic skin disorders.
Israel -
hebraisk -
Ministry of Health
רפלגל
takeda israel ltd - agalsidase alfa - תרכיז להכנת תמיסה לאינפוזיה - agalsidase alfa 1 mg/ml - agalsidase alfa - agalsidase alfa - replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (alfa-galactosidase a deficiency).
Israel -
hebraisk -
Ministry of Health
ויפריב 400
takeda israel ltd - velaglucerase alfa - lyophilized powder for infusion - velaglucerase alfa 400 u/vial - velaglucerase alfa - velaglucerase alfa - vpriv is a hydrolytic glucocerebroside – specific enzyme indicated for the long term replacement therapy (ert) for pediatric and adult patients with type 1 gaucher disease.
Israel -
hebraisk -
Ministry of Health
המופיל אם פקטור נגד המופיליה (הומני) שיטה אם מונוקלונלי מטוהר
takeda israel ltd - factor viii (human) - אבקה להכנת תמיסה לזריקה - factor viii (human) 220 - 2000 iu/vial - coagulation factor viii - coagulation factor viii - hemophilia a - for the prevention and control of hemorrhagic episodes
Israel -
hebraisk -
Ministry of Health
מפקט
takeda israel ltd - mifamurtide - powder for suspension for infusion - mifamurtide 4 mg/vial - mifamurtide - mifamurtide - mepact is indicated in children, adolescents and young adults for the treatment of high grade resectable non metastatic osteosarcoma after macroscopically complete surgical resection. it is used in combination with post operative multi-agent chemotherapy. safety and efficacy have been assessed in studies of patients 2 to 30 years of age at initial diagnosis.